Wrap Technologies (NASDAQ: WRAP) reported third-quarter 2026 revenue of $1.5 million, unchanged from the prior-year period, but the company’s longer-term trajectory and a recent regulatory decision could reshape its position in the public safety technology market. For the first nine months of the year, revenue climbed 43% to $4.7 million, driven by a 174% surge in product sales to $3.9 million. That performance, detailed in the company’s latest earnings release, underscores growing adoption of its non-lethal restraint devices and training programs. Investors can view the full press release at https://ibn.fm/PxLaQ.
The third quarter itself showed mixed results. While product sales rose 20% to $1.3 million, gross profit declined to $0.8 million from $0.9 million, and gross margin narrowed to approximately 55% from 59%. Net loss widened to $3.9 million from $2.8 million, primarily due to higher noncash share-based compensation. For the nine-month period, however, gross profit rose 56% to $3.1 million, and gross margin expanded to about 66% from 60%, reflecting a more efficient product mix and cost management.
A major development during the quarter was the U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives’ classification of the BolaWrap 150 as an instrument of restraint. That decision matters because it provides regulatory clarity for law enforcement agencies considering the device, potentially accelerating adoption. Wrap Technologies also made a strategic investment in Frenel Imaging Ltd. to support the detection component of its WrapShield platform, signaling an expansion beyond restraint devices into integrated situational awareness tools.
The company ended the quarter with $12.1 million in cash and cash equivalents, up 249% from $3.5 million at year-end 2025, following a registered direct offering that generated approximately $12 million in gross proceeds. Net cash used in operating activities for the first nine months improved 30% to $5.3 million from $7.6 million in the comparable 2025 period, indicating better cash discipline even as the net loss widened on noncash charges. These figures suggest Wrap has bolstered its balance sheet to fund ongoing product development and market expansion.
For stakeholders, the ATF classification and the Frenel Imaging investment are the most consequential items. They position Wrap Technologies to compete more effectively in the non-lethal response market, where agencies seek alternatives that support de-escalation. The nine-month revenue growth and margin improvement demonstrate that demand for its core products is rising, even if quarterly results can be uneven. As the company continues to scale, its ability to convert regulatory wins and strategic investments into sustained revenue will be key. More information about Wrap Technologies is available through Wrap Technologies (NASDAQ: WRAP), and the latest updates can be found in the company’s newsroom at https://ibn.fm/WRAP.


